Startups
Discovery and development of new classes of safe and effective therapeutic agents for the treatment of cardiovascular disease
Overview
Employees
10001+
Total raised
$43M
Founded date
2005
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Aug 3, 2010 | Funding round | $15M |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 13, 2012 | Cardioxyl Pharmaceuticals Raises $28M in Series B Financing | Cardioxyl Pharmaceuticals, Inc., a Chapel Hill, NC-based clinical-stage pharmaceutical company, has raised $28m in Series B financing. The round was led by OrbiMed Advisors, with participation from new investor Osage University Partners and... |
| Nov 7, 2012 | Biopharmaceutical startup developing heart failure therapeutic raises more than $28M | Solution/product: The drug development company’s lead product in its pipeline, CXL-1020 is a compound designed to treat acute decompensated heart failure, the top reason for hospitalization among adults aged 65 or older in the US. The condi... |
| Aug 3, 2010 | Cardioxyl Pharmaceuticals Secures Additional $15M in Funding | Cardioxyl Pharmaceuticals, Inc., a Chapel Hill, NC-based clinical-stage pharmaceutical company developing novel therapeutic agents for the treatment of cardiovascular disease, has raised $15 million in funding. Investors include existing ba... |
| Biopharmaceutical startup developing heart failure therapeutic raises more than $28M | Company name: Cardioxyl Pharmaceuticals Industry: Pharmaceuticals Location: Chapel Hill, North Carolina Solution/product: The drug development company’s lead product in its pipeline, CXL-1020 is a compound designed to treat acute decompensa... |
Reviews 0
FAQ about Cardioxyl Pharmaceuticals
When was Cardioxyl Pharmaceuticals founded?
Cardioxyl Pharmaceuticals was founded in 2005.
How much funding has Cardioxyl Pharmaceuticals raised?
Cardioxyl Pharmaceuticals has raised $43M in total across 2 funding rounds.
What funding rounds has Cardioxyl Pharmaceuticals raised?
Parsers VC lists 2 funding rounds of Cardioxyl Pharmaceuticals, among them a funding round of $15M on Aug 3, 2010.
What has the press written about Cardioxyl Pharmaceuticals?
Parsers VC has collected 5 articles mentioning Cardioxyl Pharmaceuticals, among them “Cardioxyl Pharmaceuticals Raises $28M in Series B Financing” (Nov 13, 2012) and “Biopharmaceutical startup developing heart failure therapeutic raises more than $28M” (Nov 7, 2012).
Is Cardioxyl Pharmaceuticals still active?
Yes, Cardioxyl Pharmaceuticals is active; its latest activity on Parsers VC dates from Jul 7, 2021.